Combination therapy of TKIs and ICIs for the treatment of anaplastic thyroid carcinoma
ObjectiveTo explore the efficacy of combination therapy of tyrosine kinase inhibitor (TKIs) and immune checkpoint inhibitor (ICIs) in patients with anaplastic thyroid carcinoma (ATC).MethodThis study enrolled 7 patients with ATC between June 2020 and June 2024, and conducted follow-up for a minimum...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1564865/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|